5027-65-6

Usage

Uses

Used in Pharmaceutical Industry:
3,5-PYRIDINECARBOXYLIC ACID, 3-METHYL ESTER is used as a precursor in the synthesis of various drugs and pharmaceuticals, playing a crucial role in the development of new medicinal compounds.
Used in Organic Synthesis:
3,5-PYRIDINECARBOXYLIC ACID, 3-METHYL ESTER is used as a building block in organic synthesis, contributing to the creation of a wide range of chemical products.
Used in Agrochemical Manufacturing:
3,5-PYRIDINECARBOXYLIC ACID, 3-METHYL ESTER is used as a key component in the production of agrochemicals, aiding in the development of effective solutions for agricultural applications.
Used in Dye Manufacturing:
3,5-PYRIDINECARBOXYLIC ACID, 3-METHYL ESTER is utilized in the manufacturing of dyes, where its chemical properties contribute to the creation of diverse colorants for various industries.

InChI:InChI=1/C8H7NO4/c1-13-8(12)6-2-5(7(10)11)3-9-4-6/h2-4H,1H3,(H,10,11)

Upstream product

• 4591-55-3 dimethyl pyridine-3,5-dicarboxylate 
• 67-56-1 methanol 
• 499-81-0 3,5-Pyridinedicarboxylic acid 

Downstream Products

• 24242-17-9 5-carbamoylpyridine-3-carboxylic acid 
• 183013-75-4 5-[4-(4-Formyl-benzyloxy)-2-hydroxy-3-propyl-benzoyl]-nicotinic acid 
• 1213235-15-4 methyl 5-[(2-{[1-(3,4,5-trichlorobenzyl)-1H-1,2,3-triazol-4-yl]carbonyl}hydrazino)carbonyl]nicotinate 
• 1312555-26-2 C₄₀H₄₀N₂O₃ 
• 1312555-28-4 C₅₄H₅₂N₆O₂ 
• 1312555-30-8 C₅₄H₅₂N₆O₃ 
• 1461658-54-7 C₂₄H₂₉N₁₁O₄ 
• 1461658-38-7 NO₃^(1-)*C₂₅H₃₂N₁₁O₄⁽¹⁺⁾ 
• 1619906-81-8 C₂₁H₂₄N₂O₆ 
• 1619906-87-4 C₄₄H₅₁N₅O₁₀ 
• 1619906-89-6 C₄₅H₅₄N₅O₁₀⁽¹⁺⁾*NO₃^(1-) 
• 1619906-93-2 C₄₅H₅₄N₅O₁₀⁽¹⁺⁾*I^(1-) 
• 1619906-83-0 C₂₀H₂₂N₂O₆ 

Relevant academic research and scientific papers

Probing electrostatic effects: Formation and characterization of zwitterionic ions and their neutral counterparts in the gas phase

A dipolar ion and its nonzwitterionic counterpart were generated and characterized in the gas phase. A single charge site is found to be sufficient to lower the energy of a zwitterion well below its neutral counterpart. Charge separation in a dipolar anion enables hydrogen-deuterium exchange to take place with acids over an extraordinarily large range. These results provide a basis for studying electrostatic effects and understanding mass spectroscopic processes involving large biological molecules.

DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS

The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.

Gonadotropin releasing hormone receptor antagonists

The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.

Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof

The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Chemical compounds

Provided herein are novel and useful compounds having a tryptase inhibition activity, pharmaceutical compositions comprising such compounds, and methods treating subjects suffering from a condition, disease, or disorder that can be ameliorated by the administration of an inhibitor of tryptase, e.g., asthma and inflammatory diseases, to name only a few.

Herbicidal 2-trifluoromethyl 3-pyridine carboxylic acid derivatives

There are disclosed novel 2,6-substituted-3-pyridinecarboxylic acids, esters, and salts useful as herbicides, and as intermediates which provide herbicides.